Extracellular matrix protein synthesis pathway

The "extracellular matrix protein synthesis pathway" refers to the cellular and molecular processes that lead to the production, modification, and secretion of extracellular matrix proteins—a complex network of proteins (collagens, elastin, fibronectin, proteoglycans) essential for tissue architecture, cell adhesion, and signaling[1][3][4]. The pathway involves multiple gene products and regulatory mechanisms, responding dynamically to physiological needs (e.g., tissue repair, development) and disease states (e.g., fibrosis, cancer progression)[1][6]. The ECM is not a singular therapeutic target but is modulated through targeting individual ECM components or the signaling pathways controlling their synthesis and deposition. Key clarification: This term does not refer to a distinct protein, receptor, or enzyme, but rather a complex, multistep biological process. The entry is therefore not suitable as a canonical molecular target.

Other names

Extracellular matrix synthesisECM protein synthesisECM biosynthesis pathway

Inhibitors (or stimulators) of individual ECM protein synthesis enzymes or regulatory molecules (e.g., inhibition of collagen crosslinking, TGF-β signaling modulation)